Module 2: Screening
Module 2: Screening
Table of Content (Online Version) :
- Acknowledgements
- Abbreviations and acronyms
- Definitions
- Executive summary
- 1. Introduction
-
2. Recommendations for systematic screening for TB disease in targeted populations
- 2.1 Systematic screening for TB disease among the general population
- 2.2 Systematic screening for TB disease among people with structural risk factors for TB
- 2.3 Systematic screening for TB disease among people living with HIV
- 2.4 Systematic screening for TB disease among household and other close contacts of individuals with TB disease
- 2.5 Systematic screening for TB disease in prisons and other penitentiary institutions
- 2.6 Systematic screening for TB disease among miners and others exposed to silica dust
- 2.7 Systematic screening for TB disease among people attending health care services who have clinical risk factors for TB
-
3. Recommendations for tools for systematic screening for TB disease
- 3.1 Tools for screening for TB disease among the general population and high-risk groups
- 3.2 Use of computer-aided detection software for automated reading of digital chest radiographs
-
3.3 Tools for screening for TB disease among people living with HIV
-
3.3.1 Summary of the evidence and rationale
- 3.3.1.1 WHO-recommended four-symptom screen
- 3.3.1.2 C-reactive protein
- 3.3.1.3 Chest radiography
- 3.3.1.4 Molecular WHO-recommended rapid diagnostic tests for medical inpatients living with HIV in settings with a high TB burden
- 3.3.1.5 Molecular WHO-recommended rapid diagnostic tests for all other people living with HIV
- 3.3.2 Implementation considerations for all tools for screening people living with HIV
-
3.3.1 Summary of the evidence and rationale
- 3.4 Tools for systematic screening for TB disease among children and adolescents
- 4. Monitoring and evaluation
- 5. Research gaps
- 6. References
- Supplementary Table
- Web annexes
VIEW PDF VERSION
Download PPTSuggested citation. WHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0IGO.